# US 2024/0151730 A1 · Fast protein sequencing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0151730 A1
- Document ID: US20240151730A1
- Status: Published application
- Kind: A1
- Application number: 18/336,644
- Filed: 2023-06-16
- Published: 2024-05-09
- Earliest claimed: 2018-10-04
- Assignees: Regeneron Pharmaceuticals, Inc.
- Applicants: Regeneron Pharmaceuticals, Inc.
- Inventors: Yuan Mao; Qiangwei Xia; Lichao Zhang
- Web page: https://patentgrep.com/patent/US20240151730A1

## CPC

- G01N 33/6818: {Sequencing of polypeptides}
- G01N 33/6821: {involving C-terminal degradation}
- C07K 1/128: {sequencing}
- C07K 1/14: Extraction; Separation; Purification
- C07K 16/065: {Purification, fragmentation}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 33/6851: {Methods of protein analysis involving laser desorption ionisation mass spectrometry}
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- C07K 2317/41: Glycosylation, sialylation, or fucosylation
- C12Y 304/23001: Pepsin A (3.4.23.1)
- C12Y 304/23018: Aspergillopepsin I (3.4.23.18)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12Y: ENZYMES

## Abstract

Methods of sequencing a protein using a novel digestion-on-emitter technology are provided.

## Claims

### Claim 1

A method of analyzing at least one protein in a sample and identifying at least one post-translational modification of said protein, said method comprising:
mixing a protease enzyme with said sample to form a final sample;
contacting the final sample to an electrospray emitter, wherein digestion of said protein by said protease enzyme occurs on the electrospray emitter;
analyzing the final sample using a tandem mass spectrometry; and
identifying the at least one post-translational modification of said protein, wherein the digestion of the protein is monitored in real-time.

### Claim 2 (depends on 1)

The method of claim 1, wherein the protein is denatured.

### Claim 3 (depends on 2)

The method of claim 2, wherein the protein is denatured before contacting the final sample to the electrospray emitter.

### Claim 4 (depends on 1)

The method of claim 1, wherein the protein is reduced.

### Claim 5 (depends on 1)

The method of claim 1, wherein the protein is a therapeutic protein.

### Claim 6 (depends on 1)

The method of claim 1, wherein weight ratio of the protease enzyme to the protein in the final sample is about 1:1 to about 1:10.

### Claim 7 (depends on 1)

The method of claim 1, wherein weight ratio of the protease enzyme to the at least one protein in the final sample is about 1:5.

### Claim 8 (depends on 1)

The method of claim 1, wherein concentration of the at least one protein in the sample is less than about 10 μg/μL.

### Claim 9 (depends on 1)

The method of claim 1, wherein concentration of the at least one protein in the sample is about 1 μg/μL.

### Claim 10 (depends on 1)

The method of claim 1, wherein the at least one protein contacts the protease enzyme for a sufficient period of time to permit digestion of the at least one protein.

### Claim 11 (depends on 1)

The method of claim 1, wherein the protease enzyme is a non-specific protease.

### Claim 12 (depends on 1)

The method of claim 1, wherein the protease enzyme is protease XIII

### Claim 13 (depends on 1)

The method of claim 1, wherein the protease enzyme is pepsin.

### Claim 14 (depends on 1)

The method of claim 1, wherein the final sample contacts an electrospray ionization chip.

### Claim 15 (depends on 1)

The method of claim 1, wherein the post-translational modification is cleavage, N-terminal extensions, protein degradation, acylation of the N-terminus, biotinylation, amidation of the C-terminal, glycosylation, iodination, covalent attachment of prosthetic groups, acetylation, alkylation, methylation, adenylation, ADP-ribosylation, sulfonation, prenylation, glutamylation, glycylation, isoprenylation, lipoylation, phosphopantetheinylation, phosphorylation, or sulfation.

### Claim 16 (depends on 1)

The method of claim 1, wherein the post-translational modification is citrullination, deamidation, formation of disulfide bridges, proteolytic cleavage, ISGylation, SUMOylation, or ubiquitination.

### Claim 17 (depends on 1)

The method of claim 1, further comprising aspirating the final sample.

### Claim 18 (depends on 1)

The method of claim 1, wherein the protein is an antibody, a globular protein, or a fusion protein.

### Claim 19 (depends on 1)

The method of claim 1, wherein the tandem mass spectrometry uses a positive voltage.

### Claim 20 (depends on 1)

The method of claim 1, wherein a period of time to analyze the final sample is less than about an hour.
